Sopachem is particularly pleased to announce the launch of SARS-CoV-2 UTAB FS assay. The test for quantitative determination of total antibodies against the severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) allows to detect an already passed infection and serves to verify the efficacy of new vaccines.
The test provides comparable results on almost all clinical chemistry analyzers. It enables reliable monitoring of patients, which is currently a major challenge, especially in the context of testing the efficacy of new vaccines, as available antibody tests have different reaction principles and can usually only be used on the manufacturers’ platforms.
The liquid stable, ready-to-use reagent with matched calibrators, controls and sample dilution matrix is available now.
Find more information on the SARS-CoV-2 Universal Total AntiBody Assay Product Page